We are live on ! Find out more
ASBPW

Aspire Biopharma Warrant
ASBPW

35 hedge funds and large institutions have $823K invested in Aspire Biopharma Warrant in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $726K → $823K (+$96.6K)

10% less funds holding

Funds holding: 39 → 35 (-4)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
35
Holders Change
-4
Holders Change %
-10.26%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
4
Calls
$2.21M
Puts
–
Net Calls
+$2.21M
Net Calls Change
-$143K

Top Buyers

Rank Fund Capital Flow
1
FSI
Flow State Investments
Illinois
+$159

Top Sellers

Rank Fund Capital Flow
1
RCM
Radcliffe Capital Management
Pennsylvania
-$8.12K
2
SRCM
Sage Rock Capital Management
New York
-$8.12K
3
HIM
HGC Investment Management
Ontario, Canada
-$5.07K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$105
5
CS
Clear Street
New York
-$58
Name Holding Trade Value Shares
Change 		Change in
Stake
PMAM
26
Picton Mahoney Asset Management
Ontario, Canada
$3K – – –
Walleye Capital
27
Walleye Capital
New York
$2.79K – – –
MTCM
28
Mint Tower Capital Management
Netherlands
$2K – – –
Walleye Trading
29
Walleye Trading
New York
$1.57K – – –
EFI
30
EHP Funds Inc
Canada
$1.5K – – –
MC
31
Meteora Capital
Florida
$1.5K – – –
OAC
32
OMERS Administration Corp
Ontario, Canada
$1.5K – – –
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$1.43K -$105 -2,547 -10%
PI
34
PEAK6 Investments
Illinois
$750 – – –
BI
35
Bulldog Investors
New Jersey
$634 – – –
IRC
36
Investors Research Corp
Georgia
$1 – – –
RCM
37
Radcliffe Capital Management
Pennsylvania
– -$8.12K -163,800 Closed
SRCM
38
Sage Rock Capital Management
New York
– -$8.12K -160,076 Closed
HIM
39
HGC Investment Management
Ontario, Canada
– -$5.07K -100,000 Closed
UBS Group
40
UBS Group
Switzerland
– -$23 -453 Closed
1
2

ASBPW Hedge Fund Activity: Q4 2023 in Review

35 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Aspire Biopharma Warrant (ASBPW) for Q4 2023, worth a combined $823K — up 13% from $726K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ASBPW and 0 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Flow State Investments, adding an estimated $159. The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $8.12K sold.

  • 35 institutional investors held Aspire Biopharma Warrant (ASBPW) as of Q4 2023, down from 39 in Q3 2023.
  • Funds reported $823K of Aspire Biopharma Warrant stock for Q4 2023, up 13% quarter-over-quarter.
  • 0 funds opened new Aspire Biopharma Warrant positions in Q4 2023 and 4 closed out, a net change of -4 holders.
  • The largest Aspire Biopharma Warrant buyer in Q4 2023 was Flow State Investments, an estimated $159 added.
  • The largest Aspire Biopharma Warrant seller in Q4 2023 was Radcliffe Capital Management, an estimated $8.12K sold.

Based on aggregated 13F filings for Q4 2023.